[1]孙涛,朱成朔.通冠丸治疗不稳定型心绞痛40例[J].西部中医药,2013,26(12):73-74.
　SUN Tao,ZHU ChengShuo.TongGuan Wan for 40 Cases of Unstable Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2013,26(12):73-74.
点击复制

通冠丸治疗不稳定型心绞痛40例
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年12期
页码:
73-74
栏目:
出版日期:
2013-12-15

文章信息/Info

Title:
TongGuan Wan for 40 Cases of Unstable Angina Pectoris
文章编号:
1004-6852(2013)12-0073-02
作者:
孙涛1，朱成朔2
1 甘肃省中医院，甘肃 兰州 735000； 2 甘肃中医学院
Author(s):
SUN Tao1, ZHU ChengShuo2
1 Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, China; 2 Gansu University of Traditional Chinese Medicine
关键词:
心绞痛; 通冠丸; 超敏C反应蛋白; 同型半胱氨酸
Keywords:
angina pectoris;  TongGuanWan;  hypersensitive C-reactive protein;  homocysteine
分类号:
R541
文献标志码:
B
摘要:
目的：观察通冠丸对不稳定型心绞痛(UA)患者血清超敏C反应蛋白(hs-CRP)、同型半胱氨酸(HCY)的影响。方法：将80例患者随机分为治疗组、对照组各40例。2组均给予西药常规治疗，治疗组在此基础上加用通冠丸，20丸/次，口服，3次/d。治疗4周后观察心绞痛临床疗效及HCY、hs-CRP的水平变化。结果：总有效率治疗组为90.0%，对照组为82.5%，2组无明显差异(P＞0.05)。2组治疗后HCY、hs-CRP值均明显下降(P＜0.05)，治疗组下降更显著(P＜0.05)。结论：通冠丸联合西药常规治疗UA临床疗效显著，可显著降低患者血清HCY和hs-CRP水平。
Abstract:
Objective: To observe the influence of TongGuanWan on hypersensitive C-reactive protein (hs-CRP) and homocysteine(HCY) of the patients with unstable angina pectoris (UA). Method: Altogether 80 patients were divided into the treatment group and the control group randomly, 40 cases each group. Both groups received routine treatment of Western medicine, the treatment group took TongGuanWan orally, 20 pills each time, three times per day. Curative effects, the changes of HCY and hs-CRP were surveyed after treating for four weeks. Result: Total effective rates of the treatment group and the control group were 90.0% and 82.5%, the comparison between both groups showed insignificant difference(P＞0.05). HCY and hs-CRP of both groups were decreased remarkably (P＜0.05), the indexes of the treatment group were reduced more notably(P＜0.05). Conclusion: TongGuanWan and routine treatment of Western medicine in treating UA could gain notable effects, which could significantly lower the levels of HCY and hs-CRP.

相似文献/References:

[1]王芳芳.益气活血方对UAP易损斑块相关血清学指标MMP—9、sCD40L、sVCAM—1水平表达的影响[J].西部中医药,2012,25(08):1.
　WANG Fang-fang.Influence of YiQi HuoXueFang on Expressions of Serological Indexes Associated to Vulnerable Plaque of Unstable Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2012,25(12):1.
[2]王凯,林文.丹红与丹参酮ⅡA治疗冠心病心绞痛疗效比较[J].西部中医药,2013,26(08):88.
　WANG Kai,LIN Wen.Comparison between DanHong Injection and Tanshinone ⅡA in Treating Angina Pectoris of Patients with Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(12):88.
[3]孙文,谢春毅△.丹红注射液治疗冠心病心绞痛临床观察[J].西部中医药,2014,27(03):5.
　SUN Wen,XIE Chunyi.Clinical Observation on DanHong Injection in Treating Coronary Heart Disease Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2014,27(12):5.
[4]高晓琴.综合护理干预对不稳定型心绞痛的治疗效果及满意度的影响[J].西部中医药,2014,27(07):110.
　GAO Xiaoqin.Influence of Comprehensive Nursing Intervention on Clinical Effects of Unstable Angina Pectoris and Nursing Satisfaction Degree[J].Western Journal of Traditional Chinese Medicine,2014,27(12):110.
[5]李政.徐凤芹治疗不稳定型静息性心绞痛经验小结[J].西部中医药,2014,27(08):24.
　LI Zheng.A Summary of Xu Fengqin′s Experience of Treating Unstable Resting Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2014,27(12):24.
[6]张丽君,赵江花,赵海红,等.心脉疏膏穴位贴敷结合西药治疗冠心病心绞痛 40 例[J].西部中医药,2014,27(09):128.
[7]张红丽,刘海荣△,王媛,等.综合护理对老年冠心病心绞痛患者生活质量的影响[J].西部中医药,2014,27(10):143.
[8]杨文军,王洪芳.47例老年不稳定型心绞痛患者综合护理体会[J].西部中医药,2014,27(10):145.
[9]王海燕,刘汉娇,邓庆丰.加味柴胡陷胸汤治疗痰热型不稳定型心绞痛25例[J].西部中医药,2015,28(04):116.
[10]王鸿燕.丹参酮注射液治疗老年不稳定型心绞痛(心血瘀阻证)50例临床观察[J].西部中医药,2013,26(05):5.
　WANG Hongyan.Observation on DanShenTong Injection in Treating 50 Cases of Senile Unstable Angina Pectoris of Heart Blood Stagnation-obstruction Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(12):5.

备注/Memo

备注/Memo:
收稿日期：2013-05-28。作者简介：孙涛(1981—)，男，硕士学位，主治医师。研究方向：老年病的中西医结合诊治。
更新日期/Last Update: 2013-12-15